To hear about similar clinical trials, please enter your email below
Trial Title:
Use of Hair to Diagnose Breast Cancer
NCT ID:
NCT00390377
Condition:
Breast Cancer
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
x-ray diffraction
hair
breast cancer
synchrotron
Study type:
Interventional
Study phase:
Phase 2
Overall status:
Unknown status
Study design:
Allocation:
Non-Randomized
Intervention model:
Single Group Assignment
Primary purpose:
Diagnostic
Masking:
Single
Intervention:
Intervention type:
Procedure
Intervention name:
Cutting scalp hair
Summary:
This study aims to perform x-ray diffraction analysis of blinded hair samples from women
with a documented health status, to validate the previous findings of James et al who
described that x-ray diffraction patterns of human hair can distinguish samples from
healthy subjects from those of diseased subjects, specifically those suffering from
breast cancer.
The primary hypothesis is that x-ray diffraction of hair can be used to distinguish hair
from patients with confirmed breast cancer from subjects without detectable breast
cancer.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Adult women (aged >20) who are undergoing mammography, and
- Who are willing and able to provide informed consent; and
- Who have usable scalp hair
Exclusion Criteria:
- Women with a history of breast cancer ever or other cancers (excluding non-melanoma
skin cancer and CIN: cervical intra-epithelial neoplasia) within 5 years.
Gender:
Female
Minimum age:
20 Years
Maximum age:
N/A
Locations:
Facility:
Name:
St George Private Hospital
Address:
City:
Sydney
Zip:
2217
Country:
Australia
Status:
Recruiting
Investigator:
Last name:
Ronald Shnier, MBBS, FRACR
Email:
Principal Investigator
Start date:
October 2006
Lead sponsor:
Agency:
Fermiscan Ltd
Agency class:
Industry
Source:
Fermiscan Ltd
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00390377
